title: Ozurdex in the management of the macular edema following retinal vein occlusion in clinical practice.
authors.affiliation: Network P1.5, Mougins, FranceOphthalmology Department, Aix Marseille Université, Hôpital Nord, Chemin de Bourrely, Marseille, FranceINT UMR 7289, Aix Marseille Université, Marseille, France.
authors.forename: Frederic
authors.initials: F
authors.lastname: Matonti
authors.forename: Franck
authors.initials: F
authors.lastname: Meyer
authors.forename: Sebastien
authors.initials: S
authors.lastname: Guigou
authors.forename: Tony
authors.initials: T
authors.lastname: Barthelemy
authors.forename: Stephane
authors.initials: S
authors.lastname: Dumas
authors.forename: Frederic
authors.initials: F
authors.lastname: Gobert
authors.forename: Christian
authors.initials: C
authors.lastname: Hajjar
authors.forename: Pierre Y
authors.initials: PY
authors.lastname: Merite
authors.forename: Eric
authors.initials: E
authors.lastname: Parrat
authors.forename: Herve
authors.initials: H
authors.lastname: Rouhette
authors.forename: Stephan
authors.initials: S
authors.lastname: Pommier
mesh_terms: D000368:Aged; D003907:Dexamethasone / Q000008:administration & dosage* / Q000009:adverse effects; D016503:Drug Delivery Systems; D004343:Drug Implants; D005938:Glucocorticoids / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007429:Intraocular Pressure / Q000502:physiology; D008269:Macular Edema / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D008875:Middle Aged; D012170:Retinal Vein Occlusion / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D019233:Retreatment; D041623:Tomography, Optical Coherence; D016896:Treatment Outcome; D014792:Visual Acuity / Q000502:physiology; D014822:Vitreous Body
chemical_list: D004343:Drug Implants; D005938:Glucocorticoids; D003907:Dexamethasone